New York State Common Retirement Fund’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $53.2M | Hold |
664,493
| – | – | 0.07% | 193 |
|
|
2025
Q4 | $56.6M | Sell |
664,493
-95,900
| -13% | -$7.87M | 0.08% | 193 |
|
|
2025
Q3 | $59.1M | Buy |
760,393
+200
| +0% | +$15.6K | 0.08% | 198 |
|
|
2025
Q2 | $59.5M | Sell |
760,193
-29,484
| -4% | -$2.2M | 0.08% | 201 |
|
|
2025
Q1 | $57.2M | Sell |
789,677
-36,800
| -4% | -$2.63M | 0.08% | 199 |
|
|
2024
Q4 | $61.2M | Buy |
826,477
+2,060
| +0.2% | +$144K | 0.08% | 194 |
|
|
2024
Q3 | $54.4M | Sell |
824,417
-63,711
| -7% | -$4.63M | 0.07% | 212 |
|
|
2024
Q2 | $82M | Sell |
888,128
-17,007
| -2% | -$1.51M | 0.11% | 167 |
|
|
2024
Q1 | $86.5M | Sell |
905,135
-132,217
| -13% | -$11.1M | 0.11% | 158 |
|
|
2023
Q4 | $79.1M | Sell |
1,037,352
-62,127
| -6% | -$4.32M | 0.11% | 169 |
|
|
2023
Q3 | $76.2M | Sell |
1,099,479
-67,298
| -6% | -$5.41M | 0.11% | 162 |
|
|
2023
Q2 | $110M | Sell |
1,166,777
-46,932
| -4% | -$4.08M | 0.14% | 136 |
|
|
2023
Q1 | $100M | Sell |
1,213,709
-46,945
| -4% | -$3.69M | 0.13% | 141 |
|
|
2022
Q4 | $94.1M | Buy |
1,260,654
+7,495
| +0.6% | +$578K | 0.13% | 147 |
|
|
2022
Q3 | $104M | Sell |
1,253,159
-77,949
| -6% | -$7.5M | 0.15% | 134 |
|
|
2022
Q2 | $127M | Sell |
1,331,108
-30,148
| -2% | -$3.12M | 0.17% | 121 |
|
|
2022
Q1 | $160M | Buy |
1,361,256
+14,795
| +1% | +$1.66M | 0.17% | 111 |
|
|
2021
Q4 | $174M | Sell |
1,346,461
-5,969
| -0.4% | -$696K | 0.18% | 111 |
|
|
2021
Q3 | $153M | Sell |
1,352,430
-35,388
| -3% | -$4.04M | 0.16% | 120 |
|
|
2021
Q2 | $144M | Sell |
1,387,818
-26,041
| -2% | -$2.45M | 0.15% | 131 |
|
|
2021
Q1 | $118M | Sell |
1,413,859
-57,784
| -4% | -$4.89M | 0.13% | 149 |
|
|
2020
Q4 | $134M | Sell |
1,471,643
-56,200
| -4% | -$4.66M | 0.15% | 134 |
|
|
2020
Q3 | $122M | Sell |
1,527,843
-61,500
| -4% | -$4.8M | 0.15% | 136 |
|
|
2020
Q2 | $110M | Buy |
1,589,343
+36,000
| +2% | +$2.56M | 0.14% | 143 |
|
|
2020
Q1 | $97.7M | Sell |
1,553,343
-7,212
| -0.5% | -$520K | 0.15% | 139 |
|
|
2019
Q4 | $121M | Sell |
1,560,555
-46,500
| -3% | -$3.63M | 0.14% | 142 |
|
|
2019
Q3 | $118M | Buy |
1,607,055
+49,155
| +3% | +$3.45M | 0.15% | 135 |
|
|
2019
Q2 | $95.9M | Buy |
1,557,900
+185,550
| +14% | +$11.2M | 0.12% | 170 |
|
|
2019
Q1 | $87.5M | Sell |
1,372,350
-3,600
| -0.3% | -$205K | 0.11% | 175 |
|
|
2018
Q4 | $70.3M | Sell |
1,375,950
-163,350
| -11% | -$8.26M | 0.1% | 194 |
|
|
2018
Q3 | $89.3M | Buy |
1,539,300
+53,700
| +4% | +$2.63M | 0.11% | 186 |
|
|
2018
Q2 | $72.1M | Sell |
1,485,600
-117,600
| -7% | -$5.49M | 0.09% | 211 |
|
|
2018
Q1 | $74.6M | Sell |
1,603,200
-34,500
| -2% | -$1.5M | 0.09% | 215 |
|
|
2017
Q4 | $61.5M | Buy |
1,637,700
+48,300
| +3% | +$1.77M | 0.07% | 259 |
|
|
2017
Q3 | $57.9M | Buy |
1,589,400
+61,800
| +4% | +$2.36M | 0.07% | 260 |
|
|
2017
Q2 | $60.2M | Buy |
1,527,600
+143,397
| +10% | +$5.23M | 0.08% | 247 |
|
|
2017
Q1 | $43.4M | Buy |
1,384,203
+3
| +0% | +$94 | 0.06% | 333 |
|
|
2016
Q4 | $43.2M | Buy |
1,384,200
+7,500
| +0.5% | +$243K | 0.06% | 317 |
|
|
2016
Q3 | $55.3M | Sell |
1,376,700
-151,500
| -10% | -$5.71M | 0.08% | 245 |
|
|
2016
Q2 | $50.8M | Sell |
1,528,200
-594,282
| -28% | -$20.3M | 0.07% | 277 |
|
|
2016
Q1 | $62.4M | Sell |
2,122,482
-27,000
| -1% | -$745K | 0.1% | 204 |
|
|
2015
Q4 | $56.6M | Sell |
2,149,482
-78,720
| -4% | -$2.04M | 0.09% | 230 |
|
|
2015
Q3 | $52.8M | Sell |
2,228,202
-302,064
| -12% | -$7.29M | 0.08% | 240 |
|
|
2015
Q2 | $60.1M | Sell |
2,530,266
-315,048
| -11% | -$7.11M | 0.09% | 226 |
|
|
2015
Q1 | $67.6M | Sell |
2,845,314
-1,013,652
| -26% | -$22.7M | 0.1% | 221 |
|
|
2014
Q4 | $81.9M | Sell |
3,858,966
-754,236
| -16% | -$15.2M | 0.12% | 174 |
|
|
2014
Q3 | $78.5M | Buy |
4,613,202
+546,594
| +13% | +$8.63M | 0.12% | 179 |
|
|
2014
Q2 | $58.2M | Buy |
4,066,608
+2,184,048
| +116% | +$29.6M | 0.09% | 240 |
|
|
2014
Q1 | $23.3M | Sell |
1,882,560
-31,800
| -2% | -$367K | 0.04% | 546 |
|
|
2013
Q4 | $21M | Sell |
1,914,360
-218,400
| -10% | -$2.46M | 0.03% | 584 |
|
|
2013
Q3 | $24.8M | Buy |
2,132,760
+46,200
| +2% | +$540K | 0.04% | 489 |
|
|
2013
Q2 | $23.4M | Buy |
+2,086,560
| New | +$24.7M | 0.04% | 471 |
|
Other funds holding EW
VCM
VPM
New York State Common Retirement Fund's EW Position: Q1 2026 in Review
New York State Common Retirement Fund held its Edwards Lifesciences (EW) position steady in Q1 2026 at 664,493 shares worth $53.2M. The position accounts for 0.07% of the portfolio, ranked #193.
New York State Common Retirement Fund first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $174M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- New York State Common Retirement Fund held 664,493 shares of Edwards Lifesciences worth $53.2M as of Q1 2026.
- New York State Common Retirement Fund left its Edwards Lifesciences share count unchanged in Q1 2026.
- Edwards Lifesciences made up 0.07% of New York State Common Retirement Fund's portfolio in Q1 2026, its #193 holding.
- New York State Common Retirement Fund first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- New York State Common Retirement Fund's Edwards Lifesciences position peaked at $174M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.